Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
8.94
+0.04 (0.45%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Codman Specialty Surgical | 1.20B | 1.14B | 1.06B | 1.02B | 1.03B | | | | | |
Codman Specialty Surgical Growth | 4.97% | 7.99% | 3.87% | -0.55% | 14.57% | | | | | |
| 434.73M | 466.89M | 482.58M | 538.10M | 517.22M | | | | | |
Tissue Technologies Growth | -6.89% | -3.25% | -10.32% | 4.04% | 8.42% | | | | | |
| 1.64B | 1.61B | 1.54B | 1.56B | 1.54B | | | | | |
| 1.53% | 4.47% | -1.03% | 0.99% | 12.43% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 189.25M | 176.61M | 193.10M | 176.48M | 182.03M | | | | | |
| 7.16% | -8.54% | 9.42% | -3.05% | 15.82% | | | | | |
| 162.67M | 158.50M | 165.22M | 170.90M | 191.33M | | | | | |
| 2.63% | -4.07% | -3.32% | -10.67% | 10.79% | | | | | |
| 1.20B | 1.19B | 1.10B | 1.13B | 1.09B | | | | | |
| 1.01% | 8.35% | -2.31% | 3.42% | 12.09% | | | | | |
| 78.58M | 82.74M | 82.53M | 83.48M | 79.56M | | | | | |
| -5.03% | 0.26% | -1.14% | 4.92% | 13.61% | | | | | |
| 1.64B | 1.61B | 1.54B | 1.56B | 1.54B | | | | | |
| 1.53% | 4.47% | -1.03% | 0.99% | 12.43% | | | | | |
Source: S&P Global Market Intelligence.